Maxim Group analyst Jason McCarthy maintained a Buy rating on Capricor Therapeutics (CAPR – Research Report) yesterday and set a price target ...

Shares of Capricor Therapeutics CAPR gained 8.4% on Thursday following the completion of the submission of a biologics ...

Una Ennis has taken to social media to describe how she and her husband Keith were told their eldest child has Duchenne ...

Deramiocel is a cell therapy that has healing effects in muscle cells. If approved, deramiocel would be a once-quarterly ...

Capricor Therapeutics has completed its US marketing application for deramiocel, a cell therapy the US biotech hopes will ...

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology firm specializing in innovative cell and exosome-based therapies for rare diseases, finalized the submission of its Biologics License ...

This milestone has triggered a $10 million milestone payment to Capricor from Nippon Shinyaku, the company's distribution ...

"The submission of the BLA marks a pivotal step for Capricor and those impacted by DMD. This BLA is the culmination of a body of work that has been focused on bringing this potentially ...

Muscular Dystrophy News Today covered the latest studies, treatment advances, and clinical trials for different types of the ...

Capricor Therapeutics (CAPR) stock gains as the company completes the U.S. marketing application for lead drug deramiocel in ...

A new study has shed light on the complex interactions between dystrophin, a protein critical to muscle stability, and its partner protein, dystrobrevin, offering new pathways for understanding and ...

THE family of two Roscommon boys who were diagnosed with a “catastrophic muscle wasting disease” have issued an urgent plea. Twins George and Isaac were diagnosed with Duchenne Muscular Dystrophy ...